The class of chemicals known as Spartan activators, also known as SPRTN, encompasses a diverse group of compounds that can activate the Spartan protein through various mechanisms related to the maintenance of genomic stability and cellular proteostasis. Despite the absence of direct interaction between these molecules and the Spartan protein, their ability to amplify cellular stress-particularly DNA damage-can lead to an upregulation of the cellular pathways that require Spartan's involvement. Spartan, a protease implicated in DNA-protein crosslink (DPC) repair, responds to the cellular milieu, particularly the presence of DNA lesions. When DNA damage occurs, Spartan can be summoned to sites of damage to facilitate repair processes. This recruitment is a crucial step in maintaining genomic integrity, and any increase in DNA damage can indirectly necessitate enhanced Spartan activity.
Furthermore, the ubiquitin-proteasome system (UPS) is critical for protein quality control, and Spartan has a role in managing proteins tagged for degradation. Chemicals that interfere with the proteasome's function lead to an accumulation of ubiquitinated proteins, which can activate Spartan due to its association with protein turnover and the response to protein damage. By inhibiting proteasome activity, these Spartan activators cause an increase in misfolded or damaged proteins that require Spartan-mediated repair or degradation. Additionally, the inhibition of enzymes responsible for post-translational modifications, such as NEDD8-activating enzyme, can affect the overall proteostasis network, indirectly necessitating the activation of Spartan to handle the altered proteome landscape. Spartan's role is pivotal in the coordination of DNA repair and proteostasis, and chemical compounds that modulate these cellular stress responses can, through their actions, lead to an increase in Spartan activity as the cell attempts to restore homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $182.00 $275.00 $726.00 | 3 | |
PARP inhibitor that could possibly activate SPRTN by amplifying the DNA damage signal, potentially increasing the need for SPRTN-mediated repair processes. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
Inhibitor of ATR kinase that could possibly activate SPRTN through the elevation of DNA damage, which may upregulate DNA repair pathways involving SPRTN. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could possibly activate SPRTN by leading to increased protein ubiquitination, potentially enhancing SPRTN's activity related to ubiquitinated substrates. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme and could possibly activate SPRTN by affecting protein turnover, which might impact SPRTN's role in proteostasis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A DNA-damaging agent forming crosslinks, which could possibly activate SPRTN by increasing the cellular requirements for its DNA repair activity. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms DNA crosslinks and could possibly activate SPRTN by causing DNA damage that raises the necessity for SPRTN-mediated repair mechanisms. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Induces replication stress, which could possibly activate SPRTN by increasing the formation of DNA-protein crosslinks, thereby elevating the demand for SPRTN's repair functions. | ||||||